Diffuse large B-cell lymphoma: reduced CD20 expression is associated with an inferior survival

CD19 and CD20 are B cell–specific antigens whose expression is heterogeneous when analyzed by flow cytometry (FCM). We determined the association between CD20 expression and clinical outcome in patients with diffuse large B-cell lymphoma (DLBCL). The mean fluorescence intensity of CD20 and CD19 was...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Johnson, Nathalie A., Boyle, Merrill, Bashashati, Ali, Leach, Stephen, Brooks-Wilson, Angela, Sehn, Laurie H., Chhanabhai, Mukesh, Brinkman, Ryan R., Connors, Joseph M., Weng, Andrew P., Gascoyne, Randy D.
Формат: Artigo
Язык:Inglês
Опубликовано: American Society of Hematology 2009
Предметы:
Lymphoid Neoplasia
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC2943836/
https://ncbi.nlm.nih.gov/pubmed/19029441
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2008-09-177469
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы